Have a personal or library account? Click to login
Comments to “Is epileptogenesis a key to treatment of childhood epileptic encephalopathies?” Cover

Comments to “Is epileptogenesis a key to treatment of childhood epileptic encephalopathies?”

By: Elena Belousova  
Open Access
|Nov 2015

References

  1. Boerma R.S., Braun K.P., van den Broek M.P., van Berkestijn F.M., Swinkels M.E., Hagebeuk E.O. et al.:Remarkable Phenytoin Sensitivity in 4 Children with SCN8A-related Epilepsy: A Molecular Neuropharmacological Approach. Neurotherapeutics, 2015, Aug. 22. [Epub ahead of print].10.1007/s13311-015-0386-2472066926297079
  2. Zhang B., McDaniel S.S., Rensing N.R., Wong M.:Vigabatrin inhibits seizures and mTOR pathway activation in a mouse model of tuberous sclerosis complex. PLoS One, 2013, 8: e57445.10.1371/journal.pone.0057445357771023437388
DOI: https://doi.org/10.21307/joepi-2015-0028 | Journal eISSN: 2299-9728 | Journal ISSN: 2300-0147
Language: English
Page range: 89 - 90
Submitted on: Nov 12, 2015
Accepted on: Nov 24, 2015
Published on: Nov 24, 2015
Published by: The Foundation of Epileptology
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year

© 2015 Elena Belousova, published by The Foundation of Epileptology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.